Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer Stock Rises
Pfizer Stock Rises After It Gets an Activist. What Starboard’s Track Record With Pharma Tells Us.
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have expressed interest in helping, The Wall Street Journal reported Sunday, citing people familiar with the matter.
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic waned.
Activist investor Starboard has informed Pfizer it has taken a stake
Starboard Value has taken a stake in Pfizer, people familiar with the matter said.The drug giant's stock price has dropped significantly since its COVID-19 vaccine rollout.Starboard's stake in Pfizer is reportedly worth about $1 billion.
1h
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
7h
on MSN
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
MM&M
17h
Activist investor takes $1B stake in Pfizer, aims to turn around company
Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...
21h
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...
FiercePharma
20h
Dupixent takes pharma DTC top spot as Pfizer's COVID drug Paxlovid makes a comeback
AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...
1h
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.
5d
Is Pfizer a Buy Right Now or a Value Trap?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The Pharma Letter
23h
Pfizer names new UK managing director
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback